Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    08-July-2000      
Issue 86 Next Update - 14:00 UTC 08:00 EST    09-July-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Back To Vidyya FDA Launches Oncology Tools Website

CDER Website Offers Access To Cancer-Related Information

With very little fanfare, the US Food and Drug Administrationís Center for Drug Evaluation and Research (CDER) internet web site has expanded its capability to provide cancer-related information for consumers, patients, and health care professionals. This new web page, Oncology Tools at, can be searched by specific types of cancer and by approved drug therapies. This will make it easier for consumers and patients to obtain information about different types of cancer and treatments, as well as clinical trials and patient support groups available to them.

Internet users can now directly access such documents as cancer drug labeling, approval summaries, and advisory committee transcripts. Specialized information is also available for health care professionals and others and includes cancer-related regulatory tools, references for performing clinical studies, and drug dose calculators.

The Oncology Tools page was developed by the Division of Oncology Drug Products with the support of CDER's Office of Training and Communications in order to make the web site more user friendly to the wide range of different groups that use it.

FDA review divisions responsible for oncology products include the Center for Drug Evaluation and Research (CDER), the Center for Biologics Evaluation and Research (CBER), the Center for Devices and Radiological Health (CDRH), the Center for Food Safety and Nutrition (CFSAN) and FDA's Office of Special Health Initiatives (OSHI). The new website includes a link to each of the other centers. FDA's Office of Special Health Issues (OSHI) works with cancer patients and cancer patient advocacy programs on issues related to the FDA drug approval process, cancer clinical trials and access to investigational therapies.

For further information about CDER's web site and this new page, please send your comments and questions to the CDER Webmaster at or use the comments form provided on the web site.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.